IDXG 0.85 (-68.52%)
US46062X3035Medical Diagnostics & ResearchDiagnostics & Research

Interpace Biosciences (IDXG) Competitor Comparison

We are evaluating the key criteria listed to compare Interpace Biosciences (IDXG) against its competitors in the Diagnostics & Research industry.

Performance 5 years - IDXG ranking 50 / 58

These are the competitors of Interpace Biosciences in the industry Diagnostics & Research ranked by performance 5 years
1. Natera NTRA
417.9
2. Lantheus Holdings LNTH
407.84
3. Medpace Holdings MEDP
315.33
4. RadNet RDNT
234.53
5. Meridian Bioscience VIVO
118.46
6. Twist Bioscience TWST
104.5
7. Danaher DHR
67.57
8. Waters WAT
65.23
9. Thermo Fisher Scientific TMO
63.65
10. DarioHealth DRIO
61.4
11. Agilent Technologies A
56.71
12. Laboratory Corp of America Holdings LH
54.15
13. IDEXX Laboratories IDXX
49.55
14. PerkinElmer PKI
48.44
15. Mettler-Toledo MTD
48.3
16. Quest Diagnostics DGX
42.87
17. Fulgent Genetics FLGT
32.49
18. Icon ICLR
29.16
19. DexCom DXCM
28.83
20. Qiagen QGEN
28.54
21. IQVIA Holdings IQV
26.89
22. CareDx CDNA
19.1
23. Charles River Laboratories CRL
16.62
24. Ortho Clinical Diagnostics Holdings OCDX
13.74
25. Heska HSKA
12.14
26. Co-Diagnostics CODX
6.45
27. Syneos Health SYNH
-16.98
28. Inotiv NOTV
-19.52
29. Anixa Biosciences ANIX
-23.73
30. Olink Holding OLK
-26.82
31. Bioventus BVS
-38.54
32. Exact Sciences EXAS
-46.02
33. Myriad Genetics MYGN
-47.05
34. Personalis PSNL
-48.86
35. NeoGenomics NEO
-50.47
36. Sotera Health SHC
-51.44
37. Guardant Health GH
-53.37
38. Sera Prognostics SERA
-53.83
39. Pacific Biosciences of California PACB
-54.84
40. Illumina ILMN
-58.25
41. Neogen NEOG
-62.17
42. Enzo Biochem ENZ
-65.26
43. MaxCyte MXCT
-74.1
44. National Research NRC
-75.23
45. Psychemedics PMD
-77.59
46. Trinity Biotech TRIB
-81.02
47. MDxHealth MDXH
-83.7
48. Precipio PRPO
-84.04
49. Global Cord Blood CO
-86.47
50. Interpace Biosciences IDXG
-86.51
51. Exagen XGN
-86.91
52. bioAffinity Technologies BIAF
-88.45
53. Biodesix BDSX
-90.65
54. Neuronetics STIM
-92.42
55. Aspira Womens Health AWH
-92.98
56. Organovo Holdings ONVO
-95.1
57. SeqLL SQL
-95.22
58. Prenetics Global PRE
-95.46

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.